Heffernan Michael Thomas has filed 12 insider transactions across 6 companies since May 2023.
Most recent transaction: a grant/award of 45000 shares of enGene Holdings Inc. ($ENGN) on July 08, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| July 8, 2025 | enGene Holdings Inc. | $ENGN | Heffernan Michael Thomas | Not found | A | Stock Option (Right to Buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| June 17, 2025 | Avalo Therapeutics, Inc. | $AVTX | Heffernan Michael Thomas | Director | A | Stock Option (Right to Buy) | 29500 | $0.00 | 29,500.0000 | 10,671,934 | 9999.99% | 0.28% |
| June 11, 2025 | Trevi Therapeutics, Inc. | $TRVI | Heffernan Michael Thomas | Not found | A | Nonstatutory Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 101,971,873 | 9999.99% | 0.04% |
| May 5, 2025 | Biohaven Ltd. | $BHVN | Heffernan Michael Thomas | Director | A | Stock Options (Right to buy) | 31716 | $0.00 | 31,716.0000 | 102,054,499 | 9999.99% | 0.03% |
| March 25, 2025 | Avalo Therapeutics, Inc. | $AVTX | Heffernan Michael Thomas | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 10,671,934 | 9999.99% | 0.47% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Heffernan Michael Thomas | Director | A | Common Stock | 4820 | $0.00 | 50,328.0000 | 40,109,649 | 10.59% | 0.01% |
| June 13, 2024 | Trevi Therapeutics, Inc. | $TRVI | Heffernan Michael Thomas | Not found | A | Nonstatutory Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 99,033,373 | 9999.99% | 0.03% |
| May 16, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Heffernan Michael Thomas | Director | A | Common Stock | 7693 | $0.00 | 45,508.0000 | 41,438,466 | 20.34% | 0.02% |
| April 30, 2024 | Biohaven Ltd. | $BHVN | Heffernan Michael Thomas | Not found | A | Stock Option (Right to Buy) | 16592 | $0.00 | 16,592.0000 | 0 | 9999.99% | 0.00% |
| June 22, 2023 | SYNLOGIC, INC. | $SYBX | Heffernan Michael Thomas | Not found | A | Stock Option (right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| May 18, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Heffernan Michael Thomas | Director | A | Common Stock | 9792 | $0.00 | 37,815.0000 | 34,319,291 | 34.94% | 0.03% |
| May 2, 2023 | Biohaven Ltd. | $BHVN | Heffernan Michael Thomas | Not found | A | Stock Option (Right to Buy) | 52906 | $0.00 | 52,906.0000 | 0 | 9999.99% | 0.00% |